Right-to-left ventricular differences in the expression of mitochondrial hexokinase and phosphorylation of Akt

Cellular Physiology and Biochemistry

Volumn 31, Issue 1, 2013, Pages 66-79

  Waskova Arnostova, Petra ^a   Elsnicova, Barbara ^a   Kasparova, Dita ^a   Sebesta, Ondrej ^a   Novotny, Jiri ^a   Neckar, Jan ^b   Kolar, Frantisek ^b   Zurmanova, Jitka ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Akt kinase; Hexokinase isoforms; Left ventricle; Mitochondria co localization; Right ventricle

Indexed keywords

HEXOKINASE; HEXOKINASE 1; HEXOKINASE 2; MESSENGER RNA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; IMMUNOFLUORESCENCE MICROSCOPY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

RATTUS NORVEGICUS;

EID: 84872818299     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343350     Document Type: Article

References (82)

1. Wilson JE: Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 2003;206:2049-2057.
2. Aubert-Foucher E, Font B, Gautheron DC: Rabbit heart mitochondrial hexokinase: solubilization and general properties. Arch Biochem Biophys 1984;232:391-399.
3. Burcelin R, Printz RL, Kande J, Assan R, Granner DK, Girard J: Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am J Physiol 1993;265:E392-401.
4. White TK, Wilson JE: Binding of nucleoside triphosphates, inorganic phosphate, and other polyanionic ligands to the N-terminal region of rat brain hexokinase: relationship to regulation of hexokinase activity by antagonistic interactions between glucose 6-phosphate and inorganic phosphate. Arch Biochem Biophys 1990;277:26-34.
5. Mathupala SP, Ko YH, Pedersen PL: Hexokinase-2 bound to mitochondria: cancers stygian link to the Warburg Effect and a pivotal target for effective therapy. Semin Cancer Biol 2009;19:17-24.
6. John S, Weiss JN, Ribalet B: Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS ONE 2011;6:e17674.
7. Wilson JE: An introduction to the isoenzymes of mammalian hexokinase types I-III. Biochem Soc Trans 1997;25:103-107.
8. Sebastian S, Horton JD, Wilson JE: Anabolic function of the type II isozyme of hexokinase in hepatic lipid synthesis. Biochem Biophys Res Commun 2000;270:886-891.
9. Abel ED: Glucose transport in the heart. Front Biosci 2004;9:201-215.
10. Postic C, Leturque A, Printz RL, Maulard P, Loizeau M, Granner DK, Girard J: Development and regulation of glucose transporter and hexokinase expression in rat. Am J Physiol 1994;266:E548-559.
11. Southworth R, Davey KAB, Warley A, Garlick PB: A reevaluation of the roles of hexokinase I and II in the heart. Am J Physiol Heart Circ Physiol 2007;292:H378-386.
12. Bustamante E, Pedersen PL: High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA 1977;74:3735-3739.
13. Depré C, Rider MH, Hue L: Mechanisms of control of heart glycolysis. Eur J Biochem 1998;258:277-290.
14. Bustamante E, Morris HP, Pedersen PL: Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 1981 25;256:8699-8704.
15. Miyamoto S, Murphy AN, Brown JH: Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ 2008;15:521-529.
16. Majewski N, Nogueira V, Robey RB, Hay N: Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 2004;24:730-740.
17. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N: Inhibition of early apoptotic events by Akt/ PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001;15:1406-1418.
18. da-Silva WS, Gmez-Puyou A, de Gmez-Puyou MT, Moreno-Sanchez R, De Felice FG, de Meis L, Oliveira MF, Galina A: Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J Biol Chem 2004;279:39846-39855.
19. Anflous-Pharayra K, Cai Z-J, Craigen WJ: VDAC1 serves as a mitochondrial binding site for hexokinase in oxidative muscles. Biochim Biophys Acta 2007;1767:136-142.
20. Rosano C: Molecular model of hexokinase binding to the outer mitochondrial membrane porin (VDAC1): Implication for the design of new cancer therapies. Mitochondrion 2011;11:513-519.
21. Shoshan-Barmatz V, Zakar M, Rosenthal K, Abu-Hamad S: Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim Biophys Acta 2009;1787:421-430.
22. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V: In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 2004;377:347-355.
23. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, Thompson CB, Robey RB, Hay N: Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004;16:819-830.
24. Pastorino JG, Hoek JB: Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr Med Chem 2003;10:1535-1551.
25. Pastorino JG, Shulga N, Hoek JB: Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 2002;277:7610-7618.
26. Beutner G, Rck A, Riede B, Brdiczka D: Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1998;1368:7-18.
27. Schindler A, Foley E: A functional RNAi screen identifies hexokinase 1 as a modifier of type II apoptosis. Cell Signal 2010;22:1330-1340.
28. Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, Rasola A: Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS ONE 2008;3:e1852.
29. Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H: Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol 2008;28:1007-1017.
30. Ahmad A, Ahmad S, Schneider BK, Allen CB, Chang L-Y, White CW: Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. Am J Physiol Lung Cell Mol Physiol 2002;283:L573-584.
31. Belham M, Kruger A, Pritchard C: The Tei index identifies a differential effect on left and right ventricular function with low-dose anthracycline chemotherapy. J Am Soc Echocardiogr 2006;19:206-210.
32. Baker JE, Holman P, Kalyanaraman B, Griffith OW, Pritchard KA Jr: Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production. Ann N Y Acad Sci 1999;874:236-253.
33. DellItalia LJ: The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 1991;16:653-720.
34. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
35. Bohuslavova R, Kolar F, Kuthanova L, Neckar J, Tichopad A, Pavlinkova G: Gene expression profiling of sex differences in HIF1-dependent adaptive cardiac responses to chronic hypoxia. J Appl Physiol 2010;109:1195-1202.
36. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
37. Units of Enzyme Activity. European Journal of Biochemistry 1979;97:319-320.
38. Hlavackova M, Kozichova K, Neckar J, Kolar F, Musters RJP, Novak F, Novakova O: Up-regulation and redistribution of protein kinase C-δ in chronically hypoxic heart. Mol Cell Biochem 2010;345:271-282.
39. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A: Fiji: an open-source platform for biological-image analysis. Nat Methods 2012;9:676-682.
40. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF: A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 2004;24:4070-4081.
41. Adler J, Pagakis SN, Parmryd I: Replicate-based noise corrected correlation for accurate measurements of colocalization. J Microsc 2008;230:121-133.
42. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ: Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008;117:1436-1448.
43. Ho SY, Nihoyannopoulos P: Anatomy, echocardiography, and normal right ventricular dimensions. Heart 2006;92:i2-i13.
44. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr: Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21.
45. Walker LA, Buttrick PM: The right ventricle: biologic insights and response to disease. Curr Cardiol Rev 2009;5:22-28.
46. Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R: Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol 2011;45:1239-1247.
47. Phillips D, Aponte AM, Covian R, Neufeld E, Yu Z-X, Balaban RS: Homogenous protein programming in the mammalian left and right ventricle free walls. Physiol Genomics 2011;43:1198-1206.
48. De Tata V, Fierabracci V, Gori Z, Bergamini E: Transmural distribution of glucose metabolizing enzymes across the left and the right ventricle heart walls in three different mammalian species. Comp Biochem Physiol, B 1986;84:549-553.
49. De Tata V, Gori Z, Bergamini E: Changes in the transmural distribution of glucose-metabolizing enzymes across the left and right ventricular wall of rat heart during growth and ageing. Arch Gerontol Geriatr 1988;7:23-30.
50. Andrés A, Satrstegui J, Machado A: Development of enzymes of energy metabolism in rat heart. Biol Neonate 1984;45:78-85.
51. Bass A, Stejskalova M, Stieglerova A, Ostadal B, Samanek M: Ontogenetic development of energy-supplying enzymes in rat and guinea-pig heart. Physiol Res 2001;50:237-245.
52. Bass A, Stejskalova M, Ostadal B, Samanek M: Differences between atrial and ventricular energy-supplying enzymes in five mammalian species. Physiol Res 1993;42:1-6.
53. Rumsey WL, Abbott B, Bertelsen D, Mallamaci M, Hagan K, Nelson D, Erecinska M: Adaptation to hypoxia alters energy metabolism in rat heart. Am J Physiol 1999;276:H71-80.
54. Daneshrad Z, Garcia-Riera MP, Verdys M, Rossi A: Differential responses to chronic hypoxia and dietary restriction of aerobic capacity and enzyme levels in the rat myocardium. Mol Cell Biochem 2000;210:159-166.
55. Bondy CA, Cheng CM: Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004;490:25-31.
56. Ebrecht G, Rupp H, Jacob R: Alterations of mechanical parameters in chemically skinned preparations of rat myocardium as a function of isoenzyme pattern of myosin. Basic Res Cardiol 1982;77:220-234.
57. Pope B, Hoh JF, Weeds A: The ATPase activities of rat cardiac myosin isoenzymes. FEBS Lett 1980;118:205-208.
58. Schwartz K, Lompre AM, Bouveret P, Wisnewsky C, Whalen RG: Comparisons of rat cardiac myosins at fetal stages in young animals and in hypothyroid adults. J Biol Chem 1982;257:14412-14418.
59. Brooks WW, Bing OH, Blaustein AS, Allen PD: Comparison of contractile state and myosin isozymes of rat right and left ventricular myocardium. J Mol Cell Cardiol 1987;19:433-440.
60. Sharma S, Razeghi P, Shakir A, Keneson BJ 2nd, Clubb F, Taegtmeyer H: Regional heterogeneity in gene expression profiles: a transcript analysis in human and rat heart. Cardiology 2003;100:73-79.
61. Zuurbier CJ, Smeele KMA, Eerbeek O: Mitochondrial hexokinase and cardioprotection of the intact heart. J Bioenerg Biomembr 2009;41:181-185.
62. Shulga N, Wilson-Smith R, Pastorino JG: Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism. Cell Cycle 2009;8:3355-3364.
63. Smeele KMA, Southworth R, Wu R, Xie C, Nederlof R, Warley A, Nelson JK, van Horssen P, van den Wijngaard JP, Heikkinen S, Laakso M, Koeman A, Siebes M, Eerbeek O, Akar FG, Ardehali H, Hollmann MW, Zuurbier CJ: Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis. Circ Res 2011;108:1165-1169.
64. Parra J, Brdiczka D, Cusso R, Pette D: Enhanced catalytic activity of hexokinase by work-induced mitochondrial binding in fast-twitch muscle of rat. FEBS Lett 1997;403:279-282.
65. Riddle SR, Ahmad A, Ahmad S, Deeb SS, Malkki M, Schneider BK, Allen CB, White CW: Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am J Physiol Lung Cell Mol Physiol 2000;278:L407-416.
66. Hoggett JG, Kellett GL: Kinetics of the monomer-dimer reaction of yeast hexokinase PI. Biochem J 1992;287:567-572.
67. Aslanukov A, Bhowmick R, Guruju M, Oswald J, Raz D, Bush RA, Sieving PA, Lu X, Bock CB, Ferreira PA: RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism. PLoS Genet 2006;2:e177.
68. Magnani M, Crinelli R, Antonelli A, Casabianca A, Serafini G: The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system. Biochim Biophys Acta 1994;1206:180-190.
69. Mulichak AM, Wilson JE, Padmanabhan K, Garavito RM: The structure of mammalian hexokinase-1. Nat Struct Biol 1998;5:555-560.
70. Wilson JE: Hexokinases. Rev Physiol Biochem Pharmacol 1995;126:65-198.
71. Gregor M, Janovska A, Stefl B, Zurmanova J, Mejsnar J: Substrate channelling in a creatine kinase system of rat skeletal muscle under various pH conditions. Exp Physiol 2003;88:1-6.
72. Rose IA, Warms JV: Mitochondrial hexokinase. Release, rebinding, and location. J Biol Chem 1967;242:1635-1645.
73. Lindén M, Gellerfors P, Nelson BD: Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett 1982;141:189-192.
74. Fiek C, Benz R, Roos N, Brdiczka D: Evidence for identity between the hexokinase-binding protein and the mitochondrial porin in the outer membrane of rat liver mitochondria. Biochim Biophys Acta 1982;688:429-440.
75. Kurokawa M, Oda S, Tsubotani E, Fujiwara H, Yokoyama K, Ishibashi S: Characterization of hexokinase isoenzyme types I and II in ascites tumor cells by an interaction with mitochondrial membrane. Mol Cell Biochem 1982;45:151-157.
76. Ellison WR, Lueck JD, Fromm HJ: Studies on the kinetics and mechanism of orthophosphate activation of bovine brain hexokinase. Biochem Biophys Res Commun 1974;57:1214-1220.
77. Ellison WR, Lueck JD, Fromm HJ: Studies on the mechanism of orthophosphate regulation of bovine brain hexokinase. J Biol Chem 1975;250:1864-1871.
78. Tsai HJ, Wilson JE: Functional organization of mammalian hexokinases: characterization of chimeric hexokinases constructed from the N- and C-terminal domains of the rat type I and type II isozymes. Arch Biochem Biophys 1995;316:206-214.
79. Fang TY, Alechina O, Aleshin AE, Fromm HJ, Honzatko RB: Identification of a phosphate regulatory site and a low affinity binding site for glucose 6-phosphate in the N-terminal half of human brain hexokinase. J Biol Chem 1998;273:19548-19553.
80. Lueck JD, Fromm HJ: Kinetics, mechanism, and regulation of rat skeletal muscle hexokinase. J Biol Chem 1974;249:1341-1347.
81. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA: Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996;15:6541-6551.
82. Shaw M, Cohen P, Alessi DR: The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 1998;336:241-246.